Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Instil Bio, Inc. Common Stock (TIL)

Biological Products, (no Disgnostic Substances)

https://www.instilbio.com

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using our Co-Stimulatory Antigen Receptor, or CoStAR, platform. The company's lead product candidate, ITIL-168, is an autologous TIL therapy that it is initially developing for the treatment of PD-1-inhibitor relapsed or refractory advanced melanoma.

3963 MAPLE AVENUE, SUITE 350
DALLAS, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/19/2021

Market Cap

66,014,687

Shares Outstanding

6,500,000

Weighted SO

6,503,954

Total Employees

N/A

Upcoming Earnings

08/12/2024

Beta

1.1890

Last Div

0.0000

Range

6.08-13.95

Chg

-0.0700

Avg Vol

20530

Mkt Cap

66014687

Exch

NASDAQ

Country

US

Phone

972 499 3350

DCF Diff

23.2966

DCF

-11.5866

Div Yield

0.0000

P/S

8.6069

EV Multiple

-1.3186

P/FV

0.3385

Div Yield %

0.0000

P/E

-0.5521

PEG

-0.0182

Payout

0.0000

Current Ratio

15.0574

Quick Ratio

15.0574

Cash Ratio

0.6591

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

111.5532

CCC

-111.5532

Gross Margin

0.4808

Op Margin

-14.7168

Pretax Margin

-15.5901

Net Margin

-15.5901

Eff Tax Rate

-0.0122

ROA

-0.4063

ROE

-0.5557

ROCE

-0.3974

NI/EBT

1.0000

EBT/EBIT

1.0593

EBIT/Rev

-14.7168

Debt Ratio

0.2840

D/E

0.4287

LT Debt/Cap

0.2958

Total Debt/Cap

0.3000

Int Coverage

389.2345

CF/Debt

-0.6317

Equity Multi

1.5092

Rec Turnover

0.0000

Pay Turnover

3.2720

Inv Turnover

0.0000

FA Turnover

0.0569

Asset Turnover

0.0261

OCF/Share

-8.1199

FCF/Share

-8.9219

Cash/Share

22.8487

OCF/Sales

-6.8854

FCF/OCF

1.0988

CF Coverage

-0.6317

ST Coverage

-31.6423

CapEx Coverage

-10.1248

Div&CapEx Cov

-10.1248

P/BV

0.3385

P/B

0.3385

P/S

8.6069

P/E

-0.5521

P/FCF

-1.1377

P/OCF

-1.2500

P/CF

-1.2500

PEG

-0.0182

P/S

8.6069

EV Multiple

-1.3186

P/FV

0.3385

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation